A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Leukemia, Published online: 25 February 2020; doi:10.1038/s41375-020-0778-0A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Source: Leukemia - February 24, 2020 Category: Hematology Authors: Prithviraj Bose Srdan Verstovsek Jorge E. Cortes Susan Tse Yvonne Gasior Nitin Jain Elias J. Jabbour Zeev Estrov Yesid Alvarado Courtney D. DiNardo Naveen Pemmaraju Steven M. Kornblau Tapan M. Kadia Naval G. Daver Kiran Naqvi Nicholas J. Short Lucia Masar Source Type: research